LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

Home・Aandelen Lijst・Codexis Inc

Codexis Inc

Open

SectorGezondheidszorg

1.87 -2.6

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.88

Max

1.9300000000000002

Belangrijke statistieken
By Trading Economics
Inkomsten	-6.3M -20M
Verkoop	-6.7M 8.6M
EPS	-0.16
Winstmarge	-228.055
Werknemers	188
EBITDA	-3.4M -16M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+212.5% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-55M 149M
Vorige openingsprijs	4.47
Vorige sluitingsprijs	1.87

Nieuwssentiment

By Acuity

41%

59%

135 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

2.25 / 2.53 Steun & Weerstand

Codexis Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 nov 2025, 21:37 UTC

Winsten

Codexis to Cut About 24% of Workforce

Peer Vergelijking

Prijswijziging

Codexis Inc Prognose

Koersdoel

By TipRanks

212.5% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6 USD 212.5%

Hoogste 11 USD

Laagste 2 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Codexis Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

Buy

Hold

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Codexis Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

2.25 / 2.53Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

135 / 374 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.